Copolymer 1: An off-beat drug development story

被引：11

作者：

Scheindlin, S

机构：

来源：

MOLECULAR INTERVENTIONS | 2004年 / 4卷 / 01期

关键词：

D O I：

10.1124/mi.4.1.6

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：6 / 9

页数：4

共 10 条

[1]

ARNON R, 1989, ISRAEL J MED SCI, V25, P686

[2] A PILOT TRIAL OF COP-1 IN EXACERBATING REMITTING MULTIPLE-SCLEROSIS [J].

BORNSTEIN, MB ;

MILLER, A ;

SLAGLE, S ;

WEITZMAN, M ;

CRYSTAL, H ;

DREXLER, E ;

KEILSON, M ;

MERRIAM, A ;

WASSERTHEILSMOLLER, S ;

SPADA, V ;

WEISS, W ;

ARNON, R ;

JACOBSOHN, I ;

TEITELBAUM, D ;

SELA, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (07) :408-414

[3] Medical progress: Multiple sclerosis. [J].

Noseworthy, JH ;

Lucchinetti, C ;

Rodriguez, M ;

Weinshenker, BG .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (13) :938-952

[4]

PACE E, 1995, NY TIMES 0906

[5] COPOLYMER-I THERAPY FOR MULTIPLE-SCLEROSIS [J].

ROLAK, LA .

CLINICAL NEUROPHARMACOLOGY, 1987, 10 (05) :389-396

[6] STUDIES ON CHEMICAL BASIS OF ANTIGENICITY OF PROTEINS .5. SYNTHESIS, CHARACTERIZATION AND IMMUNOGENICITY OF SOME MULTICHAIN AND LINEAR POLYPEPTIDES CONTAINING TYROSINE [J].

SELA, M ;

FUCHS, S ;

ARNON, R .

BIOCHEMICAL JOURNAL, 1962, 85 (01) :223-&

[7]

TEITELBAUM D, 1973, EUR J IMMUNOL, V3, P273, DOI 10.1002/eji.1830030505

[8]

TEITELBAUM D, 1971, European Journal of Immunology, V1, P242, DOI 10.1002/eji.1830010406

[9]

2003, MOL INTERV, V3, P361

[10]

2003, PHYS DESK REFERENCE, P3214

← 1 →